Northern Trust’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-35,102
| Closed | -$222K | – | 4661 |
|
|
2022
Q4 | $222K | Hold |
35,102
| – | – | ﹤0.01% | 3820 |
|
|
2022
Q3 | $180K | Hold |
35,102
| – | – | ﹤0.01% | 3921 |
|
|
2022
Q2 | $220K | Hold |
35,102
| – | – | ﹤0.01% | 3881 |
|
|
2022
Q1 | $125K | Hold |
35,102
| – | – | ﹤0.01% | 4282 |
|
|
2021
Q4 | $176K | Sell |
35,102
-57
| -0.2% | -$344 | ﹤0.01% | 4245 |
|
|
2021
Q3 | $257K | Buy |
35,159
+707
| +2% | +$4.85K | ﹤0.01% | 4068 |
|
|
2021
Q2 | $296K | Buy |
34,452
+16,008
| +87% | +$137K | ﹤0.01% | 3944 |
|
|
2021
Q1 | $200K | Buy |
18,444
+7,994
| +76% | +$77.6K | ﹤0.01% | 4119 |
|
|
2020
Q4 | $103K | Sell |
10,450
-2,033
| -16% | -$13.3K | ﹤0.01% | 4109 |
|
|
2020
Q3 | $67K | Buy |
12,483
+1,427
| +13% | +$8.54K | ﹤0.01% | 4056 |
|
|
2020
Q2 | $65K | Buy |
11,056
+1,190
| +12% | +$6.88K | ﹤0.01% | 4008 |
|
|
2020
Q1 | $37K | Hold |
9,866
| – | – | ﹤0.01% | 4001 |
|
|
2019
Q4 | $63K | Sell |
9,866
-154
| -2% | -$1.96K | ﹤0.01% | 4016 |
|
|
2019
Q3 | $138K | Sell |
10,020
-36,705
| -79% | -$605K | ﹤0.01% | 3852 |
|
|
2019
Q2 | $690K | Buy |
46,725
+709
| +2% | +$19K | ﹤0.01% | 3467 |
|
|
2019
Q1 | $1.93M | Buy |
46,016
+3,078
| +7% | +$130K | ﹤0.01% | 3106 |
|
|
2018
Q4 | $1.78M | Buy |
42,938
+377
| +0.9% | +$17K | ﹤0.01% | 3121 |
|
|
2018
Q3 | $2.05M | Buy |
42,561
+33,082
| +349% | +$1.66M | ﹤0.01% | 3197 |
|
|
2018
Q2 | $450K | Buy |
9,479
+4,812
| +103% | +$267K | ﹤0.01% | 3621 |
|
|
2018
Q1 | $288K | Buy |
4,667
+787
| +20% | +$41.5K | ﹤0.01% | 3720 |
|
|
2017
Q4 | $209K | Buy |
3,880
+834
| +27% | +$49.6K | ﹤0.01% | 3806 |
|
|
2017
Q3 | $205K | Buy |
+3,046
| New | +$174K | ﹤0.01% | 3796 |
|
Northern Trust's FSTX Position: Q1 2023 in Review
Northern Trust sold out of F-star Therapeutics, Inc. Common Stock (FSTX) in Q1 2023, closing a stake of 35,102 shares — an estimated $222K sold.
Northern Trust first reported a position in FSTX in Q3 2017 and held it in 22 quarters. The position peaked at $2.05M in Q3 2018. 0 funds tracked by Wall St. Rank hold FSTX as of Q1 2023.
- Northern Trust reported no remaining F-star Therapeutics, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
- Northern Trust sold 35,102 F-star Therapeutics, Inc. Common Stock shares in Q1 2023, an estimated $222K.
- Northern Trust first reported a position in F-star Therapeutics, Inc. Common Stock in Q3 2017 and held it in 22 quarters.
- Northern Trust's F-star Therapeutics, Inc. Common Stock position peaked at $2.05M in Q3 2018.
- 0 funds tracked by Wall St. Rank held F-star Therapeutics, Inc. Common Stock as of Q1 2023.
Based on Northern Trust's 13F filing for Q1 2023, filed 15 May 2023.